Company: KOYNU
Filing Date: 2025-07-31
Form Type: S-1/A
Source: 0001829126-25-005627
Chunk: 174

Company: CSLM Digital Asset Acquisition Corp III, Ltd
Filing Date: 2025-07-31
Form: S-1/A
Chunk 174
---
 our initial business combination would be disproportionately dilutive to
our Class A ordinary shares.

The nominal purchase price paid by our Sponsor and advisor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.

We are offering our units
at an offering price of $10.00 per unit and the amount deposited in our trust account is initially anticipated to be $10.00 per public
share, implying an initial value of $10.00 per public share. However, our Sponsor purchased 7,666,667 Class B ordinary shares from us
for an aggregate purchase price of $25,000, or $0.03 per share, of which up to 1,000,000 founder shares remain subject to surrender for
no consideration depending on the extent to which the underwriter’s over-allotment option is exercised during this offering. Our
Sponsor has committed, pursuant to a Securities Transfer Agreement that will close immediately prior to effectiveness of the registration
statement of which this prospectus forms a part, to transfer 20,000 founder shares (or 100,000 in the aggregate) to each of the Company’s
director nominees, Christopher Bradley, Brian Rudick, Mathew August, Danel Calvillo Armendariz and Dr. Jim Kyung Soo Liew, for the sum
of $0.003 per share. As a result, the value of your public shares may be significantly diluted upon the consummation of our initial business
combination, when the founder shares are converted into public shares. For example, the following table shows the dilutive effect of
the founder shares on the implied value of the public shares upon the consummation of our initial business combination, assuming that
our equity value at that time is $192,000,000, which is the amount in cash we would have for our initial business combination in the
trust account, assuming the underwriter’s over-allotment option is not exercised and following payment of the deferred underwriting
commissions, no interest is earned on the funds held in the trust account, and no public shares are redeemed in connection with our initial
business combination, and without taking into account any other potential impacts on our valuation at such time, such as the trading
price of our public shares, the business combination transaction costs, any equity issued or cash paid to the target’s equity holders
or other third parties, or the target’s business itself, including its assets